Tag: antimicrobial

Modulight Spotlights: LASER-SHARP RESEARCH – August 2026

Laser-sharp Research / 690 nm, antibiotic resistance, antibiotics, antimicrobial, antimicrobial resistance, in vitro, laser-sharp research, LaserSharpResearch, light activation, ML6600, MRSA, nanotechnology, photodynamics, targeted therapies, targetedtherapies / August 25, 2026

Modulight Spotlights: LASER-SHARP RESEARCH – August 2026 A fresh publication from Tayyaba Hasan lab at Massachusetts General Hospital and Harvard Medical School has introduced a new solution for antibiotic-resistant bacterial strains. The team developed photoactivatable nanocarriers to enable co-delivery of antibiotic minocycline together with a light-sensitive compound into bacterial cells. When activated with a low [...]

Modulight Spotlights: LASER-SHARP RESEARCH – August 2026 Read More »

Photoactivable nanoliposomal delivery of minocycline to combat antimicrobial resistance

Scientific papers / 690 nm, antibiotics, antimicrobial, antimicrobial therapy, antimicrobialtherapy, benzoporphyrin derivative, BPD, in vitro, liposomes, ML6600, nanotechnology, PDT, photodynamics, targeted therapy / July 16, 2026

Published in: Journal of Drug Delivery Science and Technology Authors: Jose Quílez−Alburquerque, Fernanda Viana Cabral, Yanfang Feng, Tayyaba Hasan

Photoactivable nanoliposomal delivery of minocycline to combat antimicrobial resistance Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – June 2026

Laser-sharp Research / antibiotic resistance, antimicrobial, antimicrobial therapy, appendicitis, disinfection, in vitro, in vivo, intra-abdominal infection, laparoscopic surgery, laser therapy, laser-sharp research, methylene blue, ML7710, PDT, pediatric surgery, perforation, Photodynamic therapy, Photoimmunotherapy, photomedicine, translational research / June 22, 2026

Research teams led by Dr. Timothy Baran and Dr. Nicole Wilson investigated laser-activated methylene blue therapy for perforated appendicitis. Using the ML7710 laser system, the study demonstrated a feasible and safe resistance-independent antimicrobial treatment approach.

Modulight Spotlights: LASER-SHARP RESEARCH – June 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – May 2025

Laser-sharp Research / anti-infection, antibiotic resistance, antimicrobial, bacterial infection, hydrogels, in vitro, infections, laser-sharp research, ML6600, photothermal therapy, wound healing / May 13, 2025

Cheng-Yu Lai et al. at Florida International University explores a solution for antibiotic-free wound healing. A photothermally controllable hydrogel was illuminated by NIR light from ML6600 laser, causing complete eradication of bacteria.

Modulight Spotlights: LASER-SHARP RESEARCH – May 2025 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – June 2024

Laser-sharp Research / antibioticresistance, antimicrobial, antiviral, COVID-19, in vitro, infection, influenza, laser-sharp research, LaserSharpResearch, ML6600, photoinactivation / June 12, 2024

A promising new therapy against viruses was developed at University of Manitoba and Theralase Technologies. The study evaluated antiviral effectiveness of a cancer drug (Ruvidar), activated with Modulight’s ML6600 green laser.

Modulight Spotlights: LASER-SHARP RESEARCH – June 2024 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – November 2023

Laser-sharp Research / antibioticresistance, antimicrobial, Cell, drug resistance, in vitro, laser-sharp research, LaserSharpResearch, ML7710, verteporfin / November 14, 2023

Many infectious agents have developed resistance to antibiotics. To combat this problem, Professor Timothy Haystead’s team at Duke University developed a novel light-based antimicrobial strategy that targets non-essential enzyme on the surface of bacteria. Light activation was done using ML7710 with 693 nm laser light to generate reactive oxygen species that successfully sterilized the bacteria.

Modulight Spotlights: LASER-SHARP RESEARCH – November 2023 Read More »

Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development

Scientific papers / antimicrobial, Borrelia bugdorferi, Cell, drug resistance, enzyme, HtpG, in vitro, ML7710, verteporfin / November 1, 2023

Published in: Cell Chemical Biology Authors: Dave L. Carlson, Mark Kowalewski, Khaldon Bodoor, Matthew R. Redinbo, Neil Spector, Timothy A.J. Haystead Duke University

Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development Read More »

Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses

Scientific papers / antimicrobial, in vitro, in vivo, ML6600, ML7710, MRSA, Photoimmunotherapy, PIAS, PIT / October 4, 2023

Published in: Nature Protocols Authors: Tadayuki Iwase, Kimihiro Ito, Takashi Nishimura, Kei Miyakawa, Akihide Ryo, Hisataka Kobayashi, Makoto Mitsunaga The Jikei University School of Medicine

Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses Read More »

Photodynamic Therapy of an Abdominal Abscess at the Time of Percutaneous Drainage

Scientific papers / abscess, antibiotics, antimicrobial, clinical trial, methylene blue, ML7710, PDT, Photodynamic therapy / July 18, 2023

Published in: Cardiovascular and Interventional Radiology Authors: Timothy M. Baran, Ashwani Kumar Sharma

Photodynamic Therapy of an Abdominal Abscess at the Time of Percutaneous Drainage Read More »